Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

OvaScience to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call

OvaScience
Posted on: 08 Mar 18

OvaScience℠ (NASDAQ: OVAS),a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility, today announced that it will host a conference call at 4:30 p.m. ET on Thursday, March 15, 2018 to discuss fourth quarter and fiscal year 2017 financial results and provide a general corporate update.

The conference call may be accessed by dialing +1-888-424-8151 for U.S. callers and +1-847-585-4422 for international callers five minutes prior to the start of the call and providing the passcode 7278292. A live webcast of the conference call will be available online from the Investors section of the Company’s website at www.ovascience.com.

A replay of the conference call will be available from 7:00 p.m. ET on Thursday, March 15, 2018, through 11:59 p.m. ET on Thursday, March 29, 2018, and may be accessed by visiting OvaScience’s website or by dialing 1-888-843-7419 for U.S. callers and 1-630-652-3042 for international callers. The replay access code is 7278292#.

About OvaScience℠
OvaScience℠, Inc. (NASDAQ:OVAS) is a fertility company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPC℠) cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing the OvaPrime℠treatment, which could increase a woman’s egg reserve and the OvaTure℠ treatment, a potential in vitro fertilization (IVF) treatment that could help a woman produce new fertilizable eggs without hormone injections. OvaScience’s AUGMENT℠ treatment, a fertility option designed to improve IVF success rates, is available in certain IVF clinics in Canada and Japan. OvaScience treatments are not available in the United States.

###

View source version on businesswire.com: http://www.businesswire.com/news/home/20180308005339/en/

Business Wire
www.businesswire.com

Last updated on: 08/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.